Loading company…
Pandorum Technologies develops bioengineered cornea, mini liver and cell-free lung treatments from Karnataka, India.
Founded in 2011 by CEO Tuhin Bhowmick and Arun Chandru and based in Karnataka, India, Pandorum Technologies Pvt. Ltd. develops regenerative treatments and tissue engineering for impaired cornea and liver, as well as a cell-free lung treatment. In December 2025 it raised USD 18 million in Series B funding led by Protons Corporate, with participation from Galentic Pharma, Noblevast Advisory, Avinya Ventures and Burman Family Holdings. The company plans to use the funds to advance exosome-based therapies and expand in the United States, Japan and the Middle East.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in